Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.

Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1053-63. doi: 10.1002/pds.1820.

PMID:
19637402
[PubMed - indexed for MEDLINE]
2.

Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.

Matchaba P, Gitton X, Krammer G, Ehrsam E, Sloan VS, Olson M, Mellein B, Hoexter G, Orloff J, Garaud JJ.

Clin Ther. 2005 Aug;27(8):1196-214. Review.

PMID:
16199245
[PubMed - indexed for MEDLINE]
3.

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

McGettigan P, Henry D.

JAMA. 2006 Oct 4;296(13):1633-44. Epub 2006 Sep 12. Review.

PMID:
16968831
[PubMed - indexed for MEDLINE]
4.

[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].

Valat JP, Deray G, Héloire F.

Presse Med. 2006 Sep;35(9 Spec No 1):1S25-34. Review. French.

PMID:
17078592
[PubMed - indexed for MEDLINE]
5.

Stroke risk and NSAIDs: a systematic review of observational studies.

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenboom M, Perez-Gutthann S.

Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1225-36. doi: 10.1002/pds.2227. Epub 2011 Oct 3. Review.

PMID:
21971833
[PubMed - indexed for MEDLINE]
6.

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies.

McGettigan P, Henry D.

PLoS Med. 2011 Sep;8(9):e1001098. doi: 10.1371/journal.pmed.1001098. Epub 2011 Sep 27. Review.

PMID:
21980265
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.

Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P.

BMJ. 2011 Jan 11;342:c7086. doi: 10.1136/bmj.c7086. Review.

PMID:
21224324
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials.

Scott PA, Kingsley GH, Smith CM, Choy EH, Scott DL.

Ann Rheum Dis. 2007 Oct;66(10):1296-304. Epub 2007 Mar 7. Review.

PMID:
17344246
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A Review on the risk of myocardial infarction associated with the NSAID diclofenac.

Krötz F, Struthmann L.

Cardiovasc Hematol Disord Drug Targets. 2010 Mar;10(1):53-65. Review.

PMID:
20092437
[PubMed - indexed for MEDLINE]
10.

[Non-steroidal anti-inflammatory drugs and risk of stroke in older patients: current controversies and research directions].

Mangoni AA, Knights KM.

G Ital Cardiol (Rome). 2011 May;12(5):341-9. doi: 10.1714/643.7499. Review. Italian.

PMID:
21593953
[PubMed - indexed for MEDLINE]
11.

Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies.

Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA.

Eur Heart J. 2011 Jun;32(12):1484-92. doi: 10.1093/eurheartj/ehr007. Epub 2011 Feb 7. Review.

PMID:
21300732
[PubMed - indexed for MEDLINE]
Free Article
12.

Register-based studies of cardiovascular disease.

Abildstrøm SZ, Torp-Pedersen C, Madsen M.

Scand J Public Health. 2011 Jul;39(7 Suppl):165-9. doi: 10.1177/1403494810396559. Review.

PMID:
21775377
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk